Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals.

Background: Drug-induced liver injury (DILI) can be associated with certain cutaneous adverse drug reaction (cADR).

Aims: To demonstrate the prevalence of DILI in patients with cADRs. Severity and patterns of liver injury, risk factors, causal medications and outcomes are also examined.